Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2623525123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Sara N Stoner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO 80045. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Myeloid Cells, Prevotella, Pneumonia, Pneumococcal. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCD NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Clinical data link the prevalent respiratory tract anaerobe Prevotella with reduced pneumonia mortality, but the mechanisms directing Prevotella regulation of lung immune homeostasis are unclear. Here, single-cell RNA sequencing was employed to define the transcriptional immune signatures underlying improved clearance of Streptococcus pneumoniae following lung exposure to Prevotella melaninogenica . Overall, we observed a substantial shift in myeloid cell transcriptional programming from interferon-dominant to a more antibacterial profile in S. pneumoniae –infected mice after pre-exposure to P. melaninogenica , correlating with increased macrophage and neutrophil phagocytosis of S. pneumoniae and improved pathogen clearance. In neutrophils, tumor necrosis factor (TNF) signaling through TNFR2 was essential for increased antimicrobial function. Moreover, improved defense required CCR2-dependent monocyte-derived macrophages, with selective enrichment of more a mature Cxcl3+ population which was distinct from the hallmark S. pneumoniae –associated C1qa+ population enriched in the absence of effective clearance. Together, these findings inform the myeloid cell transcriptional changes associated with natural infection resistance mediated by pulmonary microbial exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine, Aurora, CO 80045.
- Department of Basic and Translational Sciences, University of Pennsylvania School of Dental Medicine, Philadelphia, PA 19104.
- Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO 80045.
- Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO 80045.
- Department of Nephrology, University Hospital Regensburg, Regensburg 93053, Germany.
ORCID-Profile: Sara N Stoner, Edward N Janoff, Sarah E Clark
Förderung
- NIAID NIH HHS
- NIDCD NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- HHS | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD)
Zitieren
APA
Stoner, S. N., Larson, E. D., Fulte, S., Shaw, S. C., Fish, E. R., Janoff, E. N., Mack, M., & Clark, S. E. (2026). Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2623525123
Vancouver
Stoner SN, Larson ED, Fulte S, Shaw SC, Fish ER, Janoff EN, et al. Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2623525123
BibTeX
@article{Stoner2026,
author = {Stoner, Sara N and Larson, Eric D and Fulte, Sam and Shaw, Steven C and Fish, Erin R and Janoff, Edward N and Mack, Matthias and Clark, Sarah E},
title = {Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2623525123}
}
EUVIMED